Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Punteggio di Wells per la TVP× | Punteggio CHA₂DS₂-VASc× | |
|---|---|---|
| Campo | Valutazione clinica | Valutazione clinica |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1994 | 2010 |
| Ideatore≠ | Philip S. Wells | Gregory Y. H. Lip, Robby Nieuwlaat, et al. |
| Tipo≠ | Venous thromboembolism risk stratification | Atrial fibrillation stroke risk stratification |
| Fonte seminale≠ | Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546. link ↗ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ |
| Alias | Wells DVT Score, DVT Wells | CHA2DS2VASc, Atrial fibrillation stroke risk |
| Correlati | 3 | 3 |
| Sintesi≠ | The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients. | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. |
| ScholarGateInsieme di dati ↗ |
|
|